Free shipping on all orders over $ 500


Cat. No. M3649
GNE-7915 Structure
Size Price Availability Quantity
10mM*1mL In DMSO USD 130 In stock
10mg USD 120 In stock
50mg USD 350 In stock
100mg USD 550 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >98%
  • COA
  • MSDS
Biological Activity

GNE-7915 is a moderately potent 5-HT2B antagonist. GNE-7915 demonstrates excellent in vitro DMPK with minimal turnover in human hepatocytes. GNE-7915 demonstrates excellent in vivo PK profiles with long half-lives, good oral exposure and high passive permeability.

Customer Product Validations & Biological Datas
Source CNS Neurosci Ther (2017). Figure 2. GNE-7915
Method Western blot
Cell Lines WT mice
Concentrations 1 and 3 μM
Incubation Time 2-h
Results In contrast, GSK2578215A and GNE-7915 at all concentrations had no effect on DA release and recovery. Western blot confirmed the dose–response inhibition by the LRRK2 inhibitions
Cell Experiment
Cell lines
Preparation method
Incubation time
Animal Experiment
Animal models BAC transgenic mice expressing human LRRK2 protein with the G2019S Parkinson’s disease mutation
Formulation Suspended in 1% microcrystalline cellulose
Dosages 50 mg/kg
Administration i.p. ; p.o.
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 443.40
Formula C19H21F4N5O3
CAS Number 1351761-44-8
Purity >98%
Solubility DMSO
Storage at -20°C

Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors.
Estrada AA, et al. J Med Chem. 2012 Nov 26;55(22):9416-33. PMID: 22985112.

Related LRRK2 Products

JH-II-127 is a highly selective LRRK2 inhibitor with an IC50 = 6.5 nM.


LRRK2-IN-1 is useful in treatment of Parkinson's disease.


GSK2578215A is a potent and selective LRRK2 kinase inhibitor with IC50 of 8.9 nM and 10.9 nM for LRRK2 (G2019S) and LRRK2 (WT), respectively.


PF-06447475 is a highly potent, selective, brain penetrant LRRK2 inhibitor with IC0 of 3 nM/11 nM for Wt LRRK2/G2019S LRRK2 respectively.


GNE-9605 is a highly potent, selective, and brain-penetrant LRRK2 inhibitor with IC50 of 19 nM.

Abmole Inhibitor Catalog 2017

Keywords: GNE-7915 supplier, LRRK2, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.